Catalent
pharma Tampa, FL · Private
Catalent is a major CDMO with extensive U.S. manufacturing footprint across 21 facilities, recently acquired by Novo Holdings in December 2024. The company serves pharma, biologics, and gene therapy markets with integrated development and manufacturing capabilities.
Catalent is a contract development and manufacturing organization (CDMO) providing drug delivery technologies, development, and manufacturing services for pharmaceuticals, biologics, gene therapies, and consumer health products. Now privately owned by Novo Holdings (acquired December 2024), the company operates across oral dose, biologics, specialty, and clinical supply segments.
Employees
16,000
Mfg Plants
16
All Facilities
22
Activity
3/10
Type
Private
Plant Locations (22 mapped)
0
Recent News
No news articles yet.
Manufacturing Plants (16)
Catalent St. Petersburg — Softgel & Consumer Health Manufacturing
St. Petersburg, FL
Primary softgel development and manufacturing facility for North America; ~500,000 sq ft; ~630+ employees; produces pharmaceutical softgels and consumer health products
Catalent Bloomington — Biologics Fill/Finish (Novo Nordisk)
Bloomington, IN
Former Catalent biologics campus (875,000 sq ft, 62 acres); specializes in sterile fill/finish for vials, prefilled syringes, lyophilized products; transferred to Novo Nordisk December 2024 as part of $16.5B acquisition deal
Catalent Greendale — Gummy & Nutraceutical Manufacturing
Greendale, IN
Gummy technology development and manufacturing; Mogul unit for gummies; high-speed bottling and pouching; organic and vegan-based nutraceuticals; consumer health supplements
Catalent Winchester — Oral Solid Dose Manufacturing
Winchester, KY
Flagship US oral solid dose manufacturing site; 190,000+ sq ft on 32 acres; produces 3+ billion patient doses per year; integrated formulation development and analytical services; $175M expansion announced 2022
Catalent Chelsea/Boston — Inhaled Dry Powder Manufacturing
Chelsea, MA
Global center of excellence for spray dry dispersion and Dry Powder Inhaler (DPI) capsule manufacture; 140,000 sq ft; spray dryers including GEA Niro SD1/SD4/SD7; capsule filling/blister packaging; potent filling capacity up to 100M capsules/year; acquired from Acorda Therapeutics
Catalent Harmans/BWI — Gene Therapy Commercial Manufacturing Campus
Harmans, MD
State-of-the-art gene therapy campus 5 miles from BWI airport; Harmans/BWI-1 (~200,000 sq ft, 10 CGMP suites, FDA/EMA approved) and Harmans/BWI-2 (~145,000 sq ft, 8 suites); AAV, lentiviral vectors, CAR-T, viral vectors; fill/finish and cold storage
Catalent Rockville — Plasmid DNA Manufacturing
Rockville, MD
Plasmid DNA process development and CGMP production; supports gene therapy and viral vector manufacturing network; analytical development services
Catalent Kansas City — Oral/Specialty & Biologics Analytical & Clinical Supply
Kansas City, MO
421,665 sq ft multi-function site; oral solid dose manufacturing including roller compaction and high-potent; biologics analytical services center of excellence; clinical packaging and distribution; DEA-controlled drug storage
Catalent Greenville (Metrics) — Oral Solid Dose Manufacturing
Greenville, NC
Acquired from Metrics Contract Services ($475M, 2017); end-to-end oral solid dosage form services; integrated formulation development, analytical, commercial manufacturing, packaging; high-potent compound handling
Catalent Morrisville/RTP — Nasal & Inhalation Manufacturing
Morrisville, NC
Center of excellence for nasal product development and manufacturing; unit-dose, bi-dose, and multidose nasal spray products; formulation development, spray characterization, device testing; dry powder and liquid pulmonary products
Catalent Princeton — Cell Therapy Manufacturing
Princeton, NJ
Acquired from Erytech Pharma ($44.5M, 2022); commercial-scale cell therapy; 16 flexible clean rooms, QC labs, warehouse; autologous and allogeneic cell therapy production (CAR-T and other advanced therapies)
Catalent Malvern — Particle Size Reduction & Analytical
Malvern, PA
Catalent Micron Technologies site; 84,000 sq ft; particle size reduction technologies for pharma; highly potent and cytotoxic compound handling; micronization, milling; analytical services including particle size analysis, microscopy, surface area
Catalent Philadelphia — Clinical Supply & Packaging
Philadelphia, PA
Clinical supply management, packaging, blinding and manufacturing; bottle, blister, and carton packaging; potent/cytotoxic handling; global distribution; FDA, MHRA, DEA approved; direct-to-patient services with on-site pharmacy
Catalent Webster/Houston — Cell Therapy Laboratory
Webster, TX
32,000 sq ft cell therapy development and manufacturing lab; supports autologous and allogeneic cell therapy programs; located in Medical Office & Life Science Campus near Houston/Johnson Space Center
Catalent Manassas — Soft Chew & Lozenge Manufacturing
Manassas, VA
Soft chew and lozenge manufacturing; state-of-the-art plant for uncooked and cooked soft chews and lozenges; dietary supplement manufacturing under GMP; consumer health focus
Catalent Madison — Biologics Manufacturing
Madison, WI
Biologics CDMO; mammalian cell line engineering and biomanufacturing using single-use systems; fill/finish, sterile injectables, ADCs, biosimilars, cell and gene therapies; located in University Research Park
Other Facilities (6)
Catalent San Diego — Clinical Supply Services
San Diego, CA · distribution
Clinical supply management, primary and secondary packaging, complex labeling, storage, global distribution, and returns management; works in tandem with the Carroll Road development facility
Catalent Global Corporate Headquarters
Tampa, FL · hq
Global corporate headquarters opened September 2025 in Bank of America Plaza; relocated from Somerset NJ after Novo Holdings acquisition
Catalent Bridgewater — Corporate Office (NJ)
Bridgewater, NJ · hq
Retained New Jersey corporate office (~150 employees) after headquarters relocation to Tampa FL; not a manufacturing site
Catalent Emeryville — Antibody-Drug Conjugate (ADC) Development
Emeryville, CA · r&d
Formerly Redwood Bioscience; proprietary SMARTag technology for site-specific bioconjugation; next-generation antibody-drug conjugate (ADC) development and production; precision protein-chemical engineering
Catalent San Diego — Early Phase Development
San Diego, CA · r&d
Early stage development of small molecule and peptide drug candidates; preformulation testing, formulation and analytical development; cGMP manufacturing for oral and injectable dosage forms; clinical packaging and worldwide distribution
Catalent Baltimore — Gene Therapy Process Development
Baltimore, MD · r&d
Located at University of Maryland BioPark; 128,000 sq ft; upstream and downstream process development of viral vectors (AAV, vaccines, oncolytic immunotherapies); Phase 1 and 2 CGMP cleanroom suites; cell and virus bank development